Rare Disease Account Specialist - Portland

Headquartered in Carlsbad, California, and with offices in Boston, Massachusetts, and Dublin, Ireland, Ionis has been at work for more than three decades discovering medical breakthroughs that have redefined life for people with serious diseases. We are pioneers in RNA-targeted medicines, and our platform continues to revolutionize drug discovery and transform lives for patients with unmet need. With five currently marketed medicines for serious diseases and an expansive late‑stage pipeline, we continue to build upon our groundbreaking innovations in science and technology to provide greater value to patients;

and we are well positioned financially to deliver on our strategic goals.

At Ionis, we pride ourselves on cultivating a challenging, motivating and rewarding environment that fosters innovation and scientific excellence. We know our success is a direct result of the exceptional talent and dedication of our employees.

With an unprecedented opportunity to change the course of human health, we look to add diverse individuals, skill sets and perspectives to our exceptional team. We continue to invest time, money, and energy into making our onsite and remote work environments a place where solid and lasting relationships are built and where our culture and employees can thrive.

We are building on our rich history, and believe our greatest achievements are ahead of us.

RARE DISEASE ACCOUNT SPECIALIST - DONIDALORSEN

The Account Specialist, reporting to the Region Director, is a field‑based role responsible for building and managing long‑term relationships with physicians and other customers for the accounts in their assigned territory. The Account Specialist is a hybrid role of providing access support and education to the accounts while also delivering key promotional messages to advocate on behalf of people suffering from Hereditary Angioedema (HAE).

The Account Specialist will represent the organization in the HAE community educating external customers such as physicians, nurses, billing managers, and office staff about the approved indication and clinical information in relation to the HAE disease state and the appropriate use of Donidalorsen once FDA approved. The Account Specialist role is also responsible for supporting healthcare provider offices with access support in a compliant manner.

The Account Specialist will possess a deep understanding of the healthcare market in their respective territory and the HAE community, including the key customers and accounts treating HAE (primarily allergists). This will include understanding the unique objectives and needs of each customer/account in their pursuit of improved patient outcomes. The Account Specialist will achieve this by building, maintaining, and leveraging networks and relationships in the local healthcare system to develop and execute effective business plans to meet customer and Ionis goals.

The Account Specialist will serve as a cross‑functional teammate: building trust and collaborating with a diverse team of people with deep functional and therapeutic area expertise and engaging effectively and compliantly across the therapeutic field teams to bring a novel treatment to people suffering from HAE our 2nd wholly owned product launch.

• Educate HCPs and office staff about Donidalorsen, its brand messages, efficacy, and safety using approved marketing materials and verbiage
• Educate HCPs and office staff on the Donidalorsen access process (including high‑level steps, payer‑specific coverage policies, typical challenges faced, etc.)
• Use tokenized patient hub data via CRM to provide patient access status updates to customers
• Raise HAE disease state awareness, educate on patient need, and instill an urgency to appropriately treat HAE
• Create positive prescribing and access support experience for HCPs and account
• Educate on Ionis patient services offerings to encourage customer/patient participation and appropriate program utilization
• Participate in conferences, congresses, and other scientific meetings to educate HCPs on HAE disease state and treatment

• Gather insights to…